Skip to content

BITE: Is a study delivering cognitive behavioural therapy to treat eating disorders in the workplace possible?

A feasibility study of the delivery of Brief Individual Treatment for Eating Disorders (BITE) in the workplace

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN45943700
Enrollment
40
Registered
2022-01-25
Start date
2021-10-05
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eating disorders Mental and Behavioural Disorders Eating disorders

Interventions

All participants who consent to this trial will be offered the CBT-T intervention facilitated by a therapist via video call. CBT-T consists of 10 weekly sessions lasting 45 to 60 minutes, plus two fol

Sponsors

University of Warwick
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Able to give informed consent 2. English speaking 3. =18 years of age 4. In employment 5. Food avoidance due to concern about losing control of eating and weight 6. Concern or distress about body weight, shape or size

Exclusion criteria

Exclusion criteria: 1. Diagnosis of anorexia nervosa 2. Body mass index <18.5 kg/m² 3. In the third trimester of pregnancy 4. Current suicidal ideation

Design outcomes

Primary

MeasureTime frame
1. Recruitment success is measured by number of participants who have consented to the full trial within 3 months of recruitment opening 2. Attrition is measured via % retention of participants through all assessments over the 10 weekly sessions and 2 follow up sessions 3. Study retention is measured through the percentage of participant attendance of all therapy sessions

Secondary

MeasureTime frame
1. Eating disorder symptoms measured using: 1.1. ED-15 at sessions 1-10 and post-intervention at 1 and 3 months 1.2. Eating Disorder Diagnostic Scale (EDDS) at baseline 1.3. Eating Disorder Examination Questionnaire at sessions 1, 4, 10 and post-intervention at 1 and 3 months 2. Mood disorder symptoms measured using the Patient Health Questionnaire-9 and Generalised Anxiety Disorder-7 at sessions 1, 4, 10 and post-intervention at 1 and 3 months 3. Work productivity measured through the Work Productivity and Activity Impairment: General Health v2.0 at baseline, session 10 and post-intervention at 1 and 3 months

Countries

England, United Kingdom

Contacts

Public ContactCharlotte Kershaw
charlotte.kershaw@warwick.ac.uk+44 (0)24 76572566

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 9, 2026